Battelle has imported four batches of processed marijuana products since early October to secure facilities in Central Ohio for a federally approved research project with the world’s largest publicly traded cannabis company.
Canopy Growth Corp., based in Smiths Falls, Ontario, Canada, has contracted with the $5 billion nonprofit research giant to help develop standardization and clinical research for its medical marijuana products and other cannabinoids, the company’s co-CEO Mark Zekulin said in a statement.
“These guys have a long history of being very well-structured in their research,” co-CEO Bruce Linton told me.
“If things are going to evolve globally, the U.S. needs to be involved,” Linton said. “We have had quite a few options that might have been faster and easier. This (Battelle) is the best one.”